Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Apply
NVL-655
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step